Ben Haynor
Stock Analyst at Lake Street
(0.30)
# 4,165
Out of 4,405 analysts
285
Total ratings
35.2%
Success rate
-4.5%
Average return
Main Sectors:
Stocks Rated by Ben Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Maintained: Buy | $12 | $7.18 | +67.13% | 11 | Jun 8, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $235 | $144.40 | +62.74% | 1 | Jun 2, 2026 | |
| TSX: PRN Profound Medical Corp. | Reiterated: Buy | $16.79 | $9.27 | +81.17% | 32 | May 18, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $50 | $27.50 | +81.82% | 1 | May 15, 2026 | |
| QTI QT Imaging Holdings | Maintained: Buy | $10 | $4.04 | +147.52% | 4 | May 14, 2026 | |
| ELMD Electromed | Reiterated: Buy | $36 | $37.14 | -3.07% | 4 | May 13, 2026 | |
| FEMY Femasys | Reiterated: Buy | $30 | $4.18 | +617.70% | 3 | May 12, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Buy | $7 | $4.06 | +72.41% | 14 | May 11, 2026 | |
| INFU InfuSystem Holdings | Reiterated: Buy | $18 | $9.14 | +91.47% | 4 | May 8, 2026 | |
| SRTS Sensus Healthcare | Reiterated: Buy | $6 → $4.5 | $2.71 | +66.05% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.65 | +201.08% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.43 | +47.33% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $15 | $8.28 | +81.16% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $26.31 | +52.03% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $17.82 | +90.80% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $5.54 | -0.72% | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $4 | $12.23 | -67.29% | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9.5 | $18.36 | -48.26% | 9 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $6.78 | n/a | 7 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 21 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.9 → $2.9 | $2.39 | n/a | 6 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $5.5 | $7.20 | n/a | 13 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.33 → $3.15 | $3.24 | n/a | 5 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.6 → $7.2 | $0.48 | n/a | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $19 | $22.10 | n/a | 4 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $8.3 | $0.0001 | n/a | 8 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $5.35 | $0.0004 | n/a | 13 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $0.5839 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.76 | n/a | 1 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.75 → $5.2 | $0.73 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.3 | $0.0003 | n/a | 1 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $70.17 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5.55 | $0.7578 | n/a | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $26 | $1.08 | n/a | 3 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.3391 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 3 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $233 → $88 | $2.30 | n/a | 7 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $12 | $2.00 | n/a | 6 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $11 | $2.55 | n/a | 5 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.75 → $6.65 | $1.69 | n/a | 3 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $0.8 → $1.55 | $0.0002 | n/a | 2 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $149.70 | n/a | 6 | Feb 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $75.37 | n/a | 5 | Feb 20, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $560.88 | n/a | 1 | Jan 30, 2014 |
Senseonics Holdings
Jun 8, 2026
Maintained: Buy
Price Target: $12
Current: $7.18
Upside: +67.13%
Nutex Health
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $235
Current: $144.40
Upside: +62.74%
Profound Medical Corp.
May 18, 2026
Reiterated: Buy
Price Target: $16.79
Current: $9.27
Upside: +81.17%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $50
Current: $27.50
Upside: +81.82%
QT Imaging Holdings
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $4.04
Upside: +147.52%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $36
Current: $37.14
Upside: -3.07%
Femasys
May 12, 2026
Reiterated: Buy
Price Target: $30
Current: $4.18
Upside: +617.70%
Treace Medical Concepts
May 11, 2026
Reiterated: Buy
Price Target: $7
Current: $4.06
Upside: +72.41%
InfuSystem Holdings
May 8, 2026
Reiterated: Buy
Price Target: $18
Current: $9.14
Upside: +91.47%
Sensus Healthcare
May 8, 2026
Reiterated: Buy
Price Target: $6 → $4.5
Current: $2.71
Upside: +66.05%
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $4.65
Upside: +201.08%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $5.43
Upside: +47.33%
May 6, 2026
Maintained: Buy
Price Target: $25 → $15
Current: $8.28
Upside: +81.16%
May 5, 2026
Reiterated: Buy
Price Target: $40
Current: $26.31
Upside: +52.03%
May 1, 2026
Reiterated: Buy
Price Target: $34
Current: $17.82
Upside: +90.80%
Apr 30, 2026
Maintained: Buy
Price Target: $5.5
Current: $5.54
Upside: -0.72%
Mar 27, 2026
Reiterated: Buy
Price Target: $13 → $4
Current: $12.23
Upside: -67.29%
Jul 29, 2025
Maintained: Buy
Price Target: $15 → $9.5
Current: $18.36
Upside: -48.26%
Jun 3, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $6.78
Upside: n/a
Mar 11, 2025
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Mar 20, 2024
Maintained: Buy
Price Target: $1.9 → $2.9
Current: $2.39
Upside: n/a
Feb 23, 2024
Maintained: Buy
Price Target: $2.5 → $5.5
Current: $7.20
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $3.33 → $3.15
Current: $3.24
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $5.6 → $7.2
Current: $0.48
Upside: n/a
Nov 21, 2023
Maintained: Buy
Price Target: $22 → $19
Current: $22.10
Upside: n/a
Nov 14, 2023
Maintained: Buy
Price Target: $20 → $8.3
Current: $0.0001
Upside: n/a
Oct 13, 2023
Maintained: Hold
Price Target: $18 → $5.35
Current: $0.0004
Upside: n/a
Oct 2, 2023
Initiated Coverage: Buy
Price Target: $19
Current: $0.5839
Upside: n/a
Sep 8, 2023
Initiated Coverage: Buy
Price Target: $15
Current: $1.76
Upside: n/a
Aug 9, 2023
Maintained: Buy
Price Target: $4.75 → $5.2
Current: $0.73
Upside: n/a
Jun 9, 2023
Initiated Coverage: Buy
Price Target: $4.3
Current: $0.0003
Upside: n/a
May 26, 2023
Reiterated: Buy
Price Target: $81
Current: $70.17
Upside: n/a
May 19, 2023
Maintained: Buy
Price Target: $10 → $5.55
Current: $0.7578
Upside: n/a
Apr 11, 2023
Maintained: Buy
Price Target: $3 → $26
Current: $1.08
Upside: n/a
Feb 17, 2023
Initiated Coverage: Buy
Price Target: $23
Current: $0.3391
Upside: n/a
Jan 23, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $233 → $88
Current: $2.30
Upside: n/a
Jul 11, 2022
Downgraded: Hold
Price Target: $25 → $12
Current: $2.00
Upside: n/a
May 18, 2021
Maintained: Buy
Price Target: $10 → $11
Current: $2.55
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $2.75 → $6.65
Current: $1.69
Upside: n/a
Nov 10, 2016
Upgraded: Buy
Price Target: $0.8 → $1.55
Current: $0.0002
Upside: n/a
Feb 26, 2016
Upgraded: Buy
Price Target: $35
Current: $149.70
Upside: n/a
Feb 20, 2014
Downgraded: Sell
Price Target: n/a
Current: $75.37
Upside: n/a
Jan 30, 2014
Downgraded: Sell
Price Target: n/a
Current: $560.88
Upside: n/a